AAA
PMN icon

Affinity Asset Advisors’s ProMIS Neurosciences PMN Stock Holding History

Affinity Asset Advisors’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,226
Closed -$38.3K – 95
2024
Q3 		$38.3K Sell
1,226
-9,412
-88% -$351K 0.01% 85
2024
Q2 		$399K Hold
10,638
– – 0.05% 91
2024
Q1 		$508K Hold
10,638
– – 0.06% 87
2023
Q4 		$306K Hold
10,638
– – 0.06% 80
2023
Q3 		$527K Buy
+10,638
New +$691K 0.15% 72

Other funds holding PMN

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
HC
Hara Capital Bellevue, Washington $200M AUM 49.32% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return

Affinity Asset Advisors's PMN Position: Q4 2024 in Review

Affinity Asset Advisors sold out of ProMIS Neurosciences (PMN) in Q4 2024, closing a stake of 1,226 shares — an estimated $38.3K sold.

Affinity Asset Advisors first reported a position in PMN in Q3 2023 and held it in 5 quarters. The position peaked at $527K in Q3 2023. 18 funds tracked by Wall St. Rank hold PMN as of Q4 2024.

  • Affinity Asset Advisors reported no remaining ProMIS Neurosciences position as of Q4 2024 after selling out during the quarter.
  • Affinity Asset Advisors sold 1,226 ProMIS Neurosciences shares in Q4 2024, an estimated $38.3K.
  • Affinity Asset Advisors first reported a position in ProMIS Neurosciences in Q3 2023 and held it in 5 quarters.
  • Affinity Asset Advisors's ProMIS Neurosciences position peaked at $527K in Q3 2023.
  • 18 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q4 2024.

Based on Affinity Asset Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.